FMED Long Call Strategy
FMED (Fidelity Disruptive Medicine ETF), in the Financial Services sector, (Asset Management industry), listed on NASDAQ.
Invests in companies that are transforming medical diagnostics, therapies, and services, from gene therapy to robotic surgery and digital health platforms.
FMED (Fidelity Disruptive Medicine ETF) trades in the Financial Services sector, specifically Asset Management, with a market capitalization of approximately $57.6M, a beta of 0.88 versus the broader market, a 52-week range of 22.802-29.073, average daily share volume of 17K, a public-listing history dating back to 2023. These structural characteristics shape how FMED etf options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.88 places FMED roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline. FMED pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.
What is a long call on FMED?
A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.
Current FMED snapshot
As of May 15, 2026, spot at $24.51, ATM IV 52.70%, expected move 15.11%. The long call on FMED below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this long call structure on FMED specifically: IV rank is unavailable in the current snapshot, so regime-based timing for FMED is inferred from ATM IV at 52.70% alone, with a market-implied 1-standard-deviation move of approximately 15.11% (roughly $3.70 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated FMED expiries trade a higher absolute premium for lower per-day decay. Position sizing on FMED should anchor to the underlying notional of $24.51 per share and to the trader's directional view on FMED etf.
FMED long call setup
The FMED long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With FMED near $24.51, the first option leg uses a $25.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed FMED chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 FMED shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $25.00 | $1.39 |
FMED long call risk and reward
- Net Premium / Debit
- -$139.00
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- -$139.00
- Breakeven(s)
- $26.39
- Risk / Reward Ratio
- Unbounded
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.
FMED long call payoff curve
Modeled P&L at expiration across a range of underlying prices for the long call on FMED. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$139.00 |
| $5.43 | -77.9% | -$139.00 |
| $10.85 | -55.7% | -$139.00 |
| $16.26 | -33.6% | -$139.00 |
| $21.68 | -11.5% | -$139.00 |
| $27.10 | +10.6% | +$71.10 |
| $32.52 | +32.7% | +$612.91 |
| $37.94 | +54.8% | +$1,154.73 |
| $43.36 | +76.9% | +$1,696.55 |
| $48.77 | +99.0% | +$2,238.37 |
When traders use long call on FMED
Long calls on FMED express a bullish thesis with defined risk; traders use them ahead of FMED catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
FMED thesis for this long call
The market-implied 1-standard-deviation range for FMED extends from approximately $20.81 on the downside to $28.21 on the upside. A FMED long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. As a Financial Services name, FMED options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to FMED-specific events.
FMED long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. FMED positions also carry Financial Services sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move FMED alongside the broader basket even when FMED-specific fundamentals are unchanged. Long-premium structures like a long call on FMED are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current FMED chain quotes before placing a trade.
Frequently asked questions
- What is a long call on FMED?
- A long call on FMED is the long call strategy applied to FMED (etf). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With FMED etf trading near $24.51, the strikes shown on this page are snapped to the nearest listed FMED chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are FMED long call max profit and max loss calculated?
- Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the FMED long call priced from the end-of-day chain at a 30-day expiry (ATM IV 52.70%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$139.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a FMED long call?
- The breakeven for the FMED long call priced on this page is roughly $26.39 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current FMED market-implied 1-standard-deviation expected move is approximately 15.11%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long call on FMED?
- Long calls on FMED express a bullish thesis with defined risk; traders use them ahead of FMED catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
- How does current FMED implied volatility affect this long call?
- Current FMED ATM IV is 52.70%; IV rank context is unavailable in the current snapshot.